The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy-Letter

Leticia G. Leon, Niccola Funel, Godefridus J. Peters, Amir Avan, Fabio Vistoli, Ugo Boggi, Elisa Giovannetti

Research output: Contribution to journal › Article › Academic › peer-review

Access to Document

@article{81802bf771ef47258d6fd34e20da8368,

title = "The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy-Letter",

author = "Leon, {Leticia G.} and Niccola Funel and Peters, {Godefridus J.} and Amir Avan and Fabio Vistoli and Ugo Boggi and Elisa Giovannetti",

year = "2016",

month = may,

day = "15",

doi = "https://doi.org/10.1158/1078-0432.CCR-16-0259",

language = "English",

volume = "22",

pages = "2594--2594",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "10",

}

TY - JOUR

T1 - The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy-Letter

AU - Leon, Leticia G.

AU - Funel, Niccola

AU - Peters, Godefridus J.

AU - Avan, Amir

AU - Vistoli, Fabio

AU - Boggi, Ugo

AU - Giovannetti, Elisa

PY - 2016/5/15

Y1 - 2016/5/15

U2 - https://doi.org/10.1158/1078-0432.CCR-16-0259

DO - https://doi.org/10.1158/1078-0432.CCR-16-0259

M3 - Article

C2 - 27179113

SN - 1078-0432

VL - 22

SP - 2594

EP - 2594

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 10

ER -